I'm not sure what you are talking about - the company said it's interested in regional partnerships just not a global deal. And yes I think Harvey has the skills needed to market a 2nd/3rd line drug in a well established market such as CML.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.